12
Views
3
CrossRef citations to date
0
Altmetric
Articles

Novel transition complexes of Co(II), Ni(II), Cu(II), and Zn(II) derived from 3-[p-(5-substituted salicylidinehydrazinocarbonyl)]phenylsydnone

, , &
Pages 285-299 | Received 27 Aug 2008, Accepted 14 Dec 2008, Published online: 18 Mar 2009
 

Abstract

Schiff bases derived from 5-substituted salicylidine 3-[p-(5-substituted salicylidinehydrazinocarbonyl)]phenylsydnones and their transition metal complexes with Co(II), Ni(II), Cu(II), and Zn(II) have been synthesized and characterized by elemental analysis, molar conductance, magnetic susceptibilities, electronic, infrared, Proton Magnetic Resonance (PMR) (1H NMR), Fast Atomic Bombardment-(FAB)-mass spectra, Electron Spin Resonance (ESR), and thermal studies. From the above spectral studies, it is concluded that the ligands viz., 3-[p-(salicylidinehydrazinocarbonyl)]phenylsydnone (L1 ); p-(vanillidine hydrazinocarbonyl)]phenylsydnone (L2 ); and 3-[p-(5′chlorosalicylicdinehydrazinecarbonyl)]-phenylsydnones (L3 ) act as bidentate molecules coordinating through azomethine nitrogen and phenolic oxygen. The ligands and their metal complexes have been screened in vitro for antibacterial, antifungal, and antitumor activities. The results indicate that the biological activity has increased on complexation. The Cu(II) complexes of the above-said ligands have proven to be antitumor agents toward the P388/s tumor cells at lower concentrations.

Acknowledgements

The authors are thankful to University Sophisticated Instrumentation Centre (USIC) for recording the FT-IR spectra and 1H NMR spectra. The authors extend their thanks to Central Drug Research Institute, Lucknow, for providing EI and FAB mass spectra. They also thank the Sophisticated Test and Instrumentation Centre (STIC) Cochin for providing the ESR spectra. The authors are also thankful to Dr. S.R. Pattan, Department of Pharmacology, Belgaum, for his support in carrying out the biological studies of the compounds.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.